High CD33-antigen Loads in Peripheral Blood Limit the Efficacy of Gemtuzumab Ozogamicin (Mylotarg®) Treatment in Acute Myeloid Leukemia Patients
Leukemia - United Kingdom
doi 10.1038/sj.leu.2403350
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2004
Authors
Publisher
Springer Science and Business Media LLC